US pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday that its board of directors has declared a dividend of USD1.73 per share of common stock for the third quarter of 2026.
This amount is unchanged from the previous quarterly dividend.
The Q3 dividend is payable on 10 September 2026, to shareholders of record at the close of business on 14 August 2026.
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases